Very low-density lipoprotein cholesterol is associated with extent and severity of coronary artery disease in patients with type 2 diabetes mellitus

被引:4
|
作者
Jia, Aimei [1 ,2 ]
Zeng, Wei [3 ]
Yu, Liuqin [4 ]
Zeng, Huirun [1 ,2 ]
Lu, Zhan [3 ]
Song, Yongyan [1 ,2 ]
机构
[1] North Sichuan Med Coll, Sch Preclin Med, Nanchong 637000, Peoples R China
[2] North Sichuan Med Coll, Nanchong Key Lab Metab Drugs & Biol Prod, Nanchong 637000, Peoples R China
[3] North Sichuan Med Coll, Affiliated Hosp, Dept Cardiol, Nanchong, Peoples R China
[4] North Sichuan Med Coll, Sch Pharm, Nanchong, Peoples R China
来源
SAGE OPEN MEDICINE | 2019年 / 7卷
关键词
Coronary artery disease; type 2 diabetes mellitus; very low-density lipoprotein cholesterol; severity; Gensini score; PARTICLE CHOLESTEROL; RISK-FACTOR; REMNANT; PREVALENCE; PREDICTS; EVENTS; WOMEN;
D O I
10.1177/2050312119871786
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Patients with type 2 diabetes mellitus usually have multiple cardiovascular disease risk factors. The objective of this study was to examine the severity and associated risk factors in coronary artery disease patients with type 2 diabetes mellitus. Methods: Two hundred and five coronary artery disease patients with type 2 diabetes mellitus and 205 age-, gender- and smoking-matched coronary artery disease patients without type 2 diabetes mellitus were recruited from the Department of Cardiology of our hospital. Demographic and clinical data were collected for all participants. Severity of coronary artery disease was assessed using Gensini scoring system, the number of diseased coronary arteries, and the extent of coronary stenosis. Results: Coronary artery disease patients with type 2 diabetes mellitus had higher Gensini scores (p < 0.01), more numbers of diseased coronary arteries (p < 0.001), and higher degrees of coronary stenosis (p = 0.05) than coronary artery disease patients without type 2 diabetes mellitus. The plasma levels of very low-density lipoprotein cholesterol (p < 0.001) and triglycerides (p < 0.001) were also higher in coronary artery disease patients with type 2 diabetes mellitus than in coronary artery disease patients without type 2 diabetes mellitus. In coronary artery disease patients with type 2 diabetes mellitus, very low-density lipoprotein cholesterol was positively correlated with Gensini scores (r = 0.15, p = 0.03), the number of diseased coronary arteries (r = 0.15, p = 0.04), and the extent of coronary stenosis (r = 0.14, p = 0.05) by partial correlation analysis after controlling for other lipid parameters, and independently associated with Gensini scores (beta = 0.18, p = 0.02) and the number of diseased coronary arteries (odds ratio = 2.09, p = 0.05) after adjusting for other cardiovascular risk factors in the following multiple regression analysis. Conclusion: Very low-density lipoprotein cholesterol may represent a marker for the severity of coronary artery disease and be a target for the treatment in diabetic patients. Further research is needed to determine whether very low-density lipoprotein cholesterol plays a causal role of coronary artery disease in diabetic patients.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] An alternative marker of low-density lipoprotein cholesterol in coronary artery disease: non-high-density lipoprotein cholesterol
    Ercan, Mujgan
    Oguz, Esra
    Yilmaz, Fatma Meric
    Bogdaycioglu, Nihal
    Unal, Kubranur
    Sahin, Deniz
    Uysal, Sema
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2015, 45 (01) : 153 - 158
  • [32] C-Reactive Protein Predicts the Severity of Coronary Artery Disease Beyond Low-Density Lipoprotein Cholesterol
    Liu, Hai-Hang
    Zhao, Dong
    Ma, Chang-Sheng
    Liu, Xiao-Hui
    Lv, Qiang
    Qi, Yue
    Li, Yan
    Ren, Jie
    Liu, Jing
    ANGIOLOGY, 2012, 63 (03) : 218 - 222
  • [33] An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease
    Ohmori, R
    Momiyama, Y
    Nagano, M
    Taniguchi, H
    Egashira, T
    Yonemura, A
    Nakamura, H
    Kondo, K
    Ohsuzu, F
    CLINICAL CARDIOLOGY, 2004, 27 (11) : 641 - +
  • [34] Small Dense Low-Density Lipoprotein Level in Newly Diagnosed Type 2 Diabetes Mellitus Patients With Normal Low-Density Lipoprotein
    Juhi, Ayesha
    Jha, Kamlesh
    Mondal, Himel
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [35] Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus
    Kotani, Kazuo
    Tashiro, Jun
    Yamazaki, Kenya
    Nakamura, Yoshitake
    Miyazaki, Akira
    Bujo, Hideaki
    Saito, Yasushi
    Kanno, Takashi
    Maekawa, Masato
    CLINICA CHIMICA ACTA, 2015, 450 : 145 - 150
  • [36] Targeting Low-Density Lipoprotein AND Dysmetabolism in Type 2 Diabetes Mellitus
    Goldberg, Ronald
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (03) : 477 - 478
  • [37] GREATER LOW-DENSITY LIPOPROTEIN CHOLESTEROL VARIABILITY INCREASES THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Hsu, Wei-Hao
    Lai, Chia-Wei
    Chen, Szu-Chia
    Chiou, Hsin-Ying Clair
    Hsiao, Pi-Jung
    Shin, Shyi-Jang
    Lee, Mei-Yueh
    ENDOCRINE PRACTICE, 2019, 25 (09) : 918 - 925
  • [38] Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes
    Pajunen, P
    Syvänne, M
    Castro, G
    Nieminen, MS
    Taskinen, MR
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2001, 35 (02) : 96 - 100
  • [39] Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus
    Bando, Yukihiro
    Tohyama, Hitomi
    Aoki, Keiko
    Kanehara, Hideo
    Hisada, Azusa
    Okafuji, Kazuhiro
    Toya, Daisyu
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2016, 6 : 1 - 7
  • [40] The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
    Xiangming Hu
    Qunzhi Liu
    Xingyuan Guo
    Weimian Wang
    Bingyan Yu
    Beijia Liang
    Yingling Zhou
    Haojian Dong
    Jijin Lin
    Cardiovascular Diabetology, 21